USC cardiology chief Saxon: 'People are using their phones for everything except their own health. We aim to change that.'

July 16, 2012 by Sony Salzman

MassDevice discusses medical devices for mobile phones and the future of networked patient care with Dr. Leslie Saxon, cardiology chief at the University of Southern California.

MassDevice.com news

As cardiology chief of the Keck School of Medicine at the University of Southern California, Dr. Leslie Saxon is spearheading a successful mobile health innovation center called the Center for Body Computing. Founded in 2010, the coalition works with engineers, device companies and thought leaders to develop mobile health software and apps.

Saxon's ultimate goal is to create a single platform that is the "epicenter of wireless health." The CBC has developed working relationships with device companies and innovators including Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX) and St. Jude Medical (NYSE:STJ). She also hosts an annual Body Computing Conference, which brings together cross-disciplinary leaders from medicine, design, gaming and pharmaceuticals.

Sign up to get our free newsletters delivered straight to your inbox

The goal of all this collaboration is a “Facebook for healthcare," where patients, doctors and manufacturers share data in a dynamic online space. With more than 5 billion people wielding mobile devices, Saxon believes it's time to re-think the way healthcare is consumed. MassDevice.com caught up with Saxon to discuss her vision for the future of mHealth.

MassDevice: How does the Center for Body Computing find fresh new ideas to develop?

Comments

Features

David Green tells MassDevice.com about the decision to split Harvard Bioscience and Harvard Apparatus Regenerative Technology, his choice to move over to the new entity and why regenerative technologies are poised to transform medicine.

Medtech veteran Dave Johnson has been with Alliqua Biomedical for less than 2 years, during which time he's overseen a major hiring spree, 3 business development deals and the company's 1st acquisition. In an interview with MassDevice.com, Johnson talks about his step-by-step perspective and where he hopes Alliqua will be in 5 years.

MassDevice.com brought together 4 of the most influential leaders in medtech to discuss the future of the industry on July 15, 2014 at DeviceTalks Boston.

Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.

Haemonetics CEO Brian Concannon discusses how the company will transform blood management in the coming years at MassDevice.com's DeviceTalks Boston event.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp